Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis

[1]  G. Feng,et al.  Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit , 2023, bioRxiv.

[2]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[3]  D. Calvisi,et al.  Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities , 2022, Journal of personalized medicine.

[4]  D. Marbach,et al.  DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF , 2022, Life Science Alliance.

[5]  John G Doench,et al.  Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers , 2021, Nature Genetics.

[6]  D. Calvisi,et al.  RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues , 2021, bioRxiv.

[7]  D. Calvisi,et al.  YAP Accelerates NOTCH Driven Cholangiocarcinogenesis via mTORC1 in Mice. , 2021, The American journal of pathology.

[8]  S. Ro,et al.  MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma , 2021, Cancers.

[9]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[10]  S. C. Chafe,et al.  Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer , 2020, Cell reports. Medicine.

[11]  Stephen Boulton,et al.  Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis , 2020, Cancers.

[12]  Z. Ren,et al.  The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma , 2020, Frontiers in Cell and Developmental Biology.

[13]  G. Zalcman,et al.  RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis—an updated review , 2019, Cell Death & Disease.

[14]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[15]  A. Singal,et al.  Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction. , 2019, Gastroenterology.

[16]  S. Keyse,et al.  Dual-specificity MAP kinase phosphatases in health and disease☆ , 2019, Biochimica et biophysica acta. Molecular cell research.

[17]  J. Ko,et al.  Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Yongmei Li,et al.  Sp1‐regulated transcription of RasGRP1 promotes hepatocellular carcinoma (HCC) proliferation , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[19]  M. Takekawa,et al.  Downregulation of dual‐specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas , 2017, Cancer science.

[20]  S. Vlahopoulos,et al.  Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode , 2017, Cancer biology & medicine.

[21]  X. Chen,et al.  Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways , 2017, Oncogene.

[22]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[23]  Zhe Shi,et al.  The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC , 2016, Oncology letters.

[24]  D. Calvisi,et al.  Activated mutant forms of PIK3CA cooperate with RasV12 or c‐Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[25]  J. Mu¨ller,et al.  The University of Bradford Institutional Repository , 2022 .

[26]  J. McCubrey,et al.  NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance , 2016, Cell Death and Disease.

[27]  K. Boberg,et al.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) , 2016, Nature Reviews Gastroenterology &Hepatology.

[28]  M. Seto,et al.  Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma. , 2016, Cancer research.

[29]  S. Thorgeirsson,et al.  Signal transducer and activator of transcription 3‐mediated CD133 up‐regulation contributes to promotion of hepatocellular carcinoma , 2015, Hepatology.

[30]  M. Woenckhaus,et al.  Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation , 2013, International journal of cancer.

[31]  J. Seong,et al.  Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging , 2013, PloS one.

[32]  S. Keyse,et al.  Dual-specificity MAP kinase phosphatases (MKPs) , 2013, The FEBS journal.

[33]  A. Gingras,et al.  Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiation. , 2012, Cell reports.

[34]  G. Gores,et al.  Cholangiocarcinomas can originate from hepatocytes in mice. , 2012, The Journal of clinical investigation.

[35]  Y. Sirivatanauksorn,et al.  Differential expression of sprouty genes in hepatocellular carcinoma , 2012, Journal of surgical oncology.

[36]  D. Calvisi,et al.  AKT (v‐akt murine thymoma viral oncogene homolog 1) and N‐Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c‐Myc pathways , 2012, Hepatology.

[37]  T. Luedde,et al.  Senescence surveillance of pre-malignant hepatocytes limits liver cancer development , 2011, Nature.

[38]  J. Blenis,et al.  The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. , 2011, Trends in biochemical sciences.

[39]  Yan Shi,et al.  Expression and prognostic role of pan-Ras, Raf-1, pMEK1 and pERK1/2 in patients with hepatocellular carcinoma. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[40]  S. Thorgeirsson,et al.  Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. , 2011, Journal of hepatology.

[41]  Xin Chen,et al.  Bmi1 Functions as an Oncogene Independent of Ink4A/Arf Repression in Hepatic Carcinogenesis , 2009, Molecular Cancer Research.

[42]  Jianren Gu,et al.  Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma , 2009, International journal of cancer.

[43]  M. Herlyn,et al.  Rewired ERK-JNK signaling pathways in melanoma. , 2007, Cancer Cell.

[44]  Corey M. Carlson,et al.  Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Steinemann,et al.  Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma , 2003, Oncogene.

[46]  D. Fell,et al.  Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells , 2000, FEBS letters.

[47]  S. Keyse,et al.  Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. , 2000, Current opinion in cell biology.

[48]  D. Woods,et al.  Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.

[49]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[50]  J. Frost,et al.  A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. R. Mickey,et al.  Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids. , 1973, Journal of the National Cancer Institute.

[52]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..